The serum tenascin C level is a marker of metabolic disorder-related inflammation affecting pancreatic cancer prognosis.
Sato K, Hikita H, Shigekawa M, Soma K, Yamauchi R, Sung J, Kato S, Sasaki Y, Kudo S, Fukumoto K, Shirai K, Murai K, Tahata Y, Yoshioka T, Nishio A, Saito Y, Kodama T, Sasaki Y, Tatsumi T, Takehara T.
Sato K, et al. Among authors: saito y.
Sci Rep. 2024 May 26;14(1):12028. doi: 10.1038/s41598-024-62498-x.
Sci Rep. 2024.
PMID: 38797735